Abstract
The efficacy, safety and toleration of sustained release verapamil (Securon SR, Knoll) and long acting propranolol (Inderal LA, ICI) in the treatment of mild to moderate hypertension were compared in a randomized, double-blind, parallel group study. Both drugs were of similar efficacy and were well tolerated in the majority of patients. However, in the verapamil SR treated group side-effects resulted in significantly fewer drug-related withdrawals.
Publication types
-
Clinical Trial
-
Comparative Study
-
Randomized Controlled Trial
MeSH terms
-
Adult
-
Aged
-
Blood Pressure / drug effects
-
Clinical Trials as Topic
-
Delayed-Action Preparations
-
Double-Blind Method
-
Female
-
Humans
-
Hypertension / drug therapy*
-
Hypertension / physiopathology
-
Male
-
Middle Aged
-
Propranolol / administration & dosage*
-
Propranolol / adverse effects
-
Propranolol / therapeutic use
-
Random Allocation
-
Verapamil / administration & dosage*
-
Verapamil / adverse effects
-
Verapamil / therapeutic use
Substances
-
Delayed-Action Preparations
-
Propranolol
-
Verapamil